Clinical Trial Update: Cryoablation+Ipilimumab+Nivolumab in Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at Massachusetts General Hospital is evaluating the combination of cryoablation with ipilimumab and nivolumab for metastatic melanoma a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Skin Cancer

Drugs mentioned

• OPDIVO (nivolumab)
• Yervoy (ipilimumab)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Metastatic Melanoma, Skin Cancer | Phase 2 | Status: RECRUITING